Kei Sakamoto is the vice executive director and Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen. Prior to this role, Kei was the Head of Metabolic Health Department at the Nestlé Institute of Health Sciences in Lausanne, Switzerland. Before that Kei was Programme Leader at the MRC Protein Phosphorylation Unit in Dundee. His research is focused on elucidating key molecular signaling mechanisms that control energy homeostasis associated with exercise, insulin resistance and type 2 diabetes. The ultimate aim of his lab is to identify and validate molecular candidates and small-molecues/natural bioactives to prevent or treat insulin resistance. He has received several awards, for examples from the American Physiological Society, the Society for Experimental Biology and Medicine, and the American College of Sports Medicine.